Published in Mol Pharmacol on January 01, 1990
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol (2005) 2.73
A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proc Natl Acad Sci U S A (2006) 2.72
Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci U S A (2004) 1.85
Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A (2009) 1.53
Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors. Naunyn Schmiedebergs Arch Pharmacol (2003) 1.00
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling. Trends Pharmacol Sci (2011) 0.97
Insights into GPCR pharmacology from the measurement of changes in intracellular cyclic AMP; advantages and pitfalls of differing methodologies. Br J Pharmacol (2010) 0.93
beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol (2010) 0.86
Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses. FASEB J (2011) 0.84
Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human β1-adrenoceptor. PLoS One (2013) 0.78
Pharmacological actions of the selective and non-selective beta-adrenoceptor antagonists celiprolol, bisoprolol and propranolol on human bronchi. Br J Pharmacol (1994) 0.75
Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification. Anesthesiology (1998) 3.44
Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol (2000) 3.13
A model of the kinetics of insulin in man. J Clin Invest (1974) 2.97
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev (1999) 2.38
Insulin control of glucose metabolism in man: a new kinetic analysis. J Clin Invest (1975) 2.09
Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J Biol Chem (2001) 2.08
Are there multiple imidazoline binding sites? Trends Pharmacol Sci (1989) 2.07
RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking. Science (2001) 2.05
The Physicians' Desk Reference. Problems and possible improvements. Arch Intern Med (1996) 2.03
Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol (1999) 1.98
Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations. N Engl J Med (1982) 1.87
Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. Proc Natl Acad Sci U S A (1997) 1.76
Endogenous nitric oxide and myocardial adaptation to ischemia. Circ Res (2000) 1.71
The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem (1993) 1.68
L-type calcium current and contractility in ventricular myocytes from mice overexpressing the cardiac beta 2-adrenoceptor. Cardiovasc Res (1999) 1.61
Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth. Science (1975) 1.51
Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. N Engl J Med (1978) 1.51
Autonomic nervous control of the urinary bladder. Acta Physiol (Oxf) (2012) 1.50
Stimulation of forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase. J Biol Chem (1982) 1.49
Stimulation of beta-adrenergic receptors of S49 lymphoma cells redistributes the alpha subunit of the stimulatory G protein between cytosol and membranes. Proc Natl Acad Sci U S A (1989) 1.46
Differential distribution of alpha subunits and beta gamma subunits of heterotrimeric G proteins on Golgi membranes of the exocrine pancreas. J Cell Biol (1996) 1.43
G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. Handb Exp Pharmacol (2008) 1.41
[Dose-escalation of SSRIS in major depressive disorder. Should not be recommended in current guidelines]. Tijdschr Psychiatr (2010) 1.40
Agonist-specific refractoriness induced by isoproterenol. Studies with mutant cells. J Biol Chem (1976) 1.39
Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways. J Biol Chem (2000) 1.39
Urinary urgency - translating the evidence base into daily clinical practice. Int J Clin Pract (2009) 1.39
A structural gene mutation affecting the regulatory subunit of cyclic AMP-dependent protein kinase in mouse lymphoma cells. Proc Natl Acad Sci U S A (1975) 1.36
Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors. Circ Res (1983) 1.32
Stoichiometry of receptor-Gs-adenylate cyclase interactions. FASEB J (1991) 1.30
Biochemical methods for detection and measurement of cyclic AMP and adenylyl cyclase activity. Methods Mol Biol (2000) 1.27
Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine. Biochem Biophys Res Commun (1980) 1.25
Quantification of signalling components and amplification in the beta-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes. Biochem J (1995) 1.25
Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving G(s). J Pharmacol Exp Ther (2000) 1.23
Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. Mol Pharmacol (2000) 1.23
Regulation of adenylate cyclase of human platelet membranes by forskolin. J Biol Chem (1982) 1.22
[3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site. Mol Pharmacol (1989) 1.22
In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans. Pharmacogenetics (2001) 1.21
Do gender, age or lifestyle factors affect responses to antimuscarinic treatment in overactive bladder patients? Int J Clin Pract (2010) 1.20
Quantitation of the guanine nucleotide binding regulatory protein Gs in S49 cell membranes using antipeptide antibodies to alpha s. J Biol Chem (1988) 1.17
Reduced beta-adrenergic receptor activation decreases G-protein expression and beta-adrenergic receptor kinase activity in porcine heart. J Clin Invest (1995) 1.17
Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A (1998) 1.17
A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing. Eur Urol (1998) 1.16
Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br J Pharmacol (2000) 1.16
Alpha 1-adrenergic receptors promote phosphatidylcholine hydrolysis in MDCK-D1 cells. A mechanism for rapid activation of protein kinase C. J Biol Chem (1988) 1.16
Alpha 1-adrenergic receptor-mediated phosphoinositide hydrolysis and prostaglandin E2 formation in Madin-Darby canine kidney cells. Possible parallel activation of phospholipase C and phospholipase A2. J Biol Chem (1987) 1.15
A new method for isolation of human lymphocyte subsets reveals differential regulation of beta-adrenergic receptors by terbutaline treatment. Clin Pharmacol Ther (1989) 1.14
Peripheral adrenergic receptors in hypertension. Hypertension (1990) 1.13
Heredity and the autonomic nervous system in human hypertension. Curr Hypertens Rep (2000) 1.12
Time-dependent decreases in binding affinity of agonists for beta-adrenergic receptors of intact S49 lymphoma cells. A mechanism of desensitization. J Biol Chem (1983) 1.12
Is alpha1D-adrenoceptor protein detectable in rat tissues? Naunyn Schmiedebergs Arch Pharmacol (1997) 1.11
Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. J Am Coll Cardiol (1989) 1.09
Verapamil competitively inhibits alpha 1-adrenergic and muscarinic but not beta-adrenergic receptors in rat myocardium. J Cardiovasc Pharmacol (1982) 1.09
Metabolism of alpha- and beta-adrenergic receptors in vitro and in vivo. Annu Rev Pharmacol Toxicol (1987) 1.09
Genetic analysis of beta-adrenergic receptor internalization and down-regulation. Proc Natl Acad Sci U S A (1985) 1.09
Subunit dissociation is the mechanism for hormonal activation of the Gs protein in native membranes. J Biol Chem (1988) 1.09
Genetic variations and polymorphisms of G protein-coupled receptors: functional and therapeutic implications. Annu Rev Pharmacol Toxicol (2001) 1.08
Beta adrenergic receptors of polymorphonuclear particulates in bronchial asthma. J Clin Invest (1980) 1.08
Spare receptors for beta-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart. J Cardiovasc Pharmacol (1992) 1.08
Influence of sodium on the alpha 2-adrenergic receptor system of human platelets. Role for intraplatelet sodium in receptor binding. J Biol Chem (1983) 1.08
A stable isotope study of zinc absorption in young men: effects of phytate and alpha-cellulose. Am J Clin Nutr (1984) 1.06
Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J Clin Invest (1990) 1.06
Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium. Naunyn Schmiedebergs Arch Pharmacol (1993) 1.05
Radioligand binding to beta adrenergic receptors of intact cultured S49 cells. Mol Pharmacol (1978) 1.04
Differentiation of beta 1- and beta 2-adrenoceptor-mediated effects in humans. Am J Physiol (1988) 1.04
Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics. Br J Clin Pharmacol (1998) 1.04
Beta-adrenergic receptors and receptor signaling in heart failure. Annu Rev Pharmacol Toxicol (1999) 1.04
Loads acting in an intramedullary nail during fracture healing in the human femur. J Biomech (2001) 1.04
Externalization of beta-adrenergic receptors promoted by myocardial ischemia. Science (1985) 1.03
beta-adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells. Am J Physiol Cell Physiol (2000) 1.03
Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. Br J Pharmacol (2000) 1.03
Differential activation of protein kinase C alpha is associated with arachidonate release in Madin-Darby canine kidney cells. J Biol Chem (1990) 1.03
Neuropeptide Y mobilizes Ca2+ and inhibits adenylate cyclase in human erythroleukemia cells. Am J Physiol (1988) 1.02
Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptor metabolism in a muscle cell line, BC3H-1. Mol Pharmacol (1986) 1.01
Pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (PPADS), a putative P2Y(1) receptor antagonist, blocks signaling at a site distal to the receptor in Madin-Darby canine kidney-D(1) cells. J Pharmacol Exp Ther (2000) 1.01
Identification and cDNA cloning of a novel human mosaic protein, LGN, based on interaction with G alpha i2. Gene (1996) 0.99
Catecholamines increase lymphocyte beta 2-adrenergic receptors via a beta 2-adrenergic, spleen-dependent process. Am J Physiol (1990) 0.99
Molecular mechanism of beta-adrenergic receptor blockers with intrinsic sympathomimetic activity. FASEB J (1988) 0.99
Alteration in Gs-mediated signal transduction in S49 lymphoma cells treated with inhibitors of microtubules. J Biol Chem (1993) 0.99
Beta adrenergic receptors and adenylate cyclase: products of separate genes? Mol Pharmacol (1976) 0.99
Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate. Urol Res (1997) 0.99
Agonist-induced redistribution of beta-adrenergic receptors on intact human mononuclear leukocytes: redistributed receptors are nonfunctional. J Clin Endocrinol Metab (1985) 0.98
Cyclic AMP-dependent protein kinase mediates a cyclic AMP-stimulated decrease in ornithine and S-adenosylmethionine decarboxylase activities. Proc Natl Acad Sci U S A (1978) 0.97
Comparison of cloned and pharmacologically defined rat tissue alpha 1-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.97
Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na. Mol Pharmacol (1982) 0.97
Subtype-selective down-regulation of rat renal cortical alpha- and beta-adrenergic receptors by catecholamines. Endocrinology (1985) 0.97
Characterization of high-affinity beta2-adrenergic receptor binding of (-)-[3H]-dihydroalprenolol to human polymorphonuclear cell particulates. J Lab Clin Med (1978) 0.96
alpha(1)-adrenoceptor subtypes differentially couple to growth promotion and inhibition in Chinese hamster ovary cells. Biochem Biophys Res Commun (2000) 0.96
Use of superoxide dismutase and catalase to protect catecholamines from oxidation in tissue culture studies. Anal Biochem (1984) 0.96
P2 purinergic receptor agonists enhance cAMP production in Madin-Darby canine kidney epithelial cells via an autocrine/paracrine mechanism. J Biol Chem (1996) 0.96
An arginine/glutamine difference at the juxtaposition of transmembrane domain 6 and the third extracellular loop contributes to the markedly different nucleotide selectivities of human and canine P2Y11 receptors. Mol Pharmacol (2001) 0.96
Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptors in cloned MDCK cells. Am J Physiol (1985) 0.96
Selective down-regulation of adrenergic receptor subtypes in tissues from rats with pheochromocytoma. Endocrinology (1983) 0.96
Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.96